Book now
← Field notes · Telehealth

Telehealth psychiatry in Idaho, Washington, Oregon, Nevada, and Arizona: how it actually works

Brandon Kruse, PMHNP-BC · · 6 min read

If you live in Idaho, Washington, Oregon, Nevada, or Arizona, you can be a patient at Embrace Psychiatry. This post explains what that actually means: how the visit works, what we can and can't prescribe over video, how insurance and cash pay differ by state, and when telehealth is the wrong tool for the job.

This is not legal advice or a comprehensive scope-of-practice document. It is a practical orientation for prospective patients, written by the clinician who would be seeing you.

Why telehealth psychiatry is solid medicine

Telepsychiatry is not a downgrade from in-person care. For medication management of stable outpatient psychiatric conditions — ADHD, anxiety, depression, OCD, mood disorders — the evidence base supports it as equivalent to in-person visits (American Psychiatric Association telepsychiatry overview).

What you get with video:

  • A full 60-minute initial evaluation without the commute, the waiting room, or the parking
  • The same clinician for every follow-up (no handoffs)
  • Visit notes and prescriptions sent the same day to your preferred pharmacy
  • Secure messaging between visits

What you don't get:

  • A physical exam
  • In-office vitals beyond what you can self-report (BP, weight, pulse if you have a cuff)
  • Same-day handling if you're in acute crisis (we'll get you to the right level of care — see "When in-person is the right call" below)

How licensure works (the short version)

Two rules govern whether a clinician can see you over video:

  1. The clinician must be licensed in the state where you, the patient, are physically located at the time of the visit. Your billing address does not matter. Your physical location during the visit does.
  2. The DEA registration must be valid in that state if controlled substances will be prescribed.

I hold active APRN licensure and a state-specific DEA registration in all five states: Idaho, Washington, Oregon, Nevada, and Arizona. That is why you have to pick the state where you'll actually be when we meet — and why we ask again at the start of every visit.

If you travel across a state line during care (move, extended trip), tell us as soon as you know. We can usually keep care going if you're in another state I'm licensed in. If you're moving to a state I'm not licensed in, I'll help you transition rather than abandon care.

State-by-state snapshot

State APRN prescribing scope DEA flexibility (current) Common payer mix
Idaho Full practice authority; no physician collaboration required Standard Mix of commercial + cash
Washington Full practice authority Standard Commercial-heavy
Oregon Full practice authority Standard Commercial-heavy
Nevada Full practice authority after 2-year transition (I meet) Standard Cash + commercial
Arizona Full practice authority Standard Mix of commercial + cash

Full practice authority means I can evaluate, diagnose, order tests, and prescribe independently — without a supervising physician — in all five states.

Insurance vs cash pay by state

We are credentialed with most major commercial plans (Aetna, Cigna, BCBS, Premera, Regence, UnitedHealthcare) across the five states. We do not currently accept Medicaid, Medicare, Tricare, or other government-sponsored plans by design — those programs reimburse below our cost to deliver the level of care we built the practice around.

Cash-pay rates are the same across all five states:

  • Initial evaluation (60 min): $400
  • Follow-up (30 min): $200

If insurance doesn't cover us in your state, you can still see us cash-pay. We provide a superbill on request for you to submit to your insurance for out-of-network reimbursement.

Controlled-substance prescribing over video

This is the question that drives most of the email we get, so I'll be direct.

Yes, we do prescribe Schedule II ADHD stimulants and other controlled substances via telehealth where state law allows. Adderall, Vyvanse, methylphenidate-based products, Concerta, and the non-stimulant controlled options are all on the table when clinically appropriate.

The federal rule: The DEA has extended COVID-era telemedicine flexibilities through December 31, 2026, allowing DEA-registered practitioners to prescribe Schedule II-V controlled substances via audio-video telemedicine without a prior in-person evaluation, provided the prescription meets all standard requirements (DEA, Dec 2025 extension). HHS and DEA have signaled they are working toward permanent rules; in the meantime the flexibility is active.

What that means for you in practice:

  • A first-visit prescription is possible but not guaranteed — it depends on diagnostic clarity and risk profile, not on it being a first visit
  • Some patients need objective testing (CNS Vital Signs, prior records) before we prescribe stimulants — this is a judgment call I make at the visit, not a blanket policy
  • I run your name through your state's prescription drug monitoring program (PDMP) before every controlled-substance prescription. This is law in all five states.
  • Out-of-state pickup of Schedule II prescriptions has limits. We send your script to the pharmacy in the state where you live and where you'll fill it.

When in-person is the right call

Telehealth is the wrong tool for some situations. We handle these case-by-case, but the categories that consistently push toward in-person referral:

  • Acute suicidality — active plan, intent, or recent attempt. We get you to crisis services (988 nationally, or your state's mobile crisis team) and coordinate handoff to a higher level of care.
  • Active substance use disorder requiring detox or medication-assisted treatment — outside our scope as a medication management practice. We refer to dedicated SUD programs.
  • Unstable medical comorbidity that affects psychiatric care — uncontrolled cardiovascular disease, active seizure disorder, severe untreated sleep apnea. We can still help, but you need an in-person primary or specialty team co-managing.
  • Psychotic symptoms requiring rapid stabilization — acute mania or first-episode psychosis usually needs in-person evaluation and often inpatient or partial hospitalization first.
  • Patient preference — if you'd rather see someone in person, we'll help you find a clinician in your area rather than push telehealth on you.

If any of these come up during care, we discuss the options openly. No clinician should be more attached to keeping you as a patient than to getting you the right care.

What a first visit looks like

Same in all five states:

  1. Book online through our secure scheduler. State of residence selected at booking.
  2. Complete the intake packet (PHQ-9, GAD-7, ASRS, medical history, ROI for prior records). 60-90 minutes of paperwork — finishing it ahead of time is what lets us use the full visit for the actual conversation.
  3. The 60-minute video visit — diagnostic interview, review of screeners and history, treatment discussion, prescribing decision if applicable.
  4. Same-day plan in writing — medication list, dose, target effect, side effects to watch for, follow-up cadence.
  5. Follow-up scheduled — 2 weeks if newly diagnosed and starting a new medication, 1 month if a dose change, 3 months once stable.

The full first-visit walkthrough is here: What to expect at an ADHD telehealth first visit.

Ready to book

If you're in ID, WA, OR, NV, or AZ and want to be evaluated, the booking link is the same across all five states:

Book a visit

Pick your state of residence at booking. If you have questions before booking, use the contact form — we read everything that comes in.

Sources and references:

This post reflects regulations current as of June 2026. Telehealth law changes frequently. If you have a question about your specific situation, contact us directly rather than relying on a blog post.

Ready to talk to a real person?

Book a visit See pricing